Furanocoumarins-imperatorin inhibits myocardial hypertrophy both in vitro and in vivo

被引：49

作者：

Zhang, Yan ^{[1
]}

Cao, YanJun ^{[1
]}

Zhan, YingZhuan ^{[1
]}

Duan, HaiJie ^{[1
]}

He, LangChong ^{[1
]}

机构：

[1] Xi An Jiao Tong Univ, Sch Med, Xian 710049, Peoples R China

来源：

FITOTERAPIA | 2010年 / 81卷 / 08期

基金：

中国国家自然科学基金;

关键词：

Imperatorin; Myocardial hypertrophy; Myocyte hypertrophy; Anti-cardiac hypertrophy agent; CELL-MEMBRANE CHROMATOGRAPHY; ATRACTYLODES-MACROCEPHALA KOIDZ; LEFT-VENTRICULAR HYPERTROPHY; INDUCED CARDIAC-HYPERTROPHY; RADIOLIGAND-BINDING ASSAY; CORONARY-HEART-DISEASE; ANGIOTENSIN-II; ATRACTYLENOLIDE-I; NATURAL-PRODUCTS; SILICA SURFACE;

D O I：

10.1016/j.fitote.2010.07.023

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The furanocoumarin imperatorin has been reported to have hypotensive effect, and we have investigated its activity on myocardial hypertrophy. Imperatorin displayed similar chromatographic retention peak to verapamil in the model of cardiac muscle/cell membrane chromatography, and could reduce in a concentration-dependent way protein content and cell size of myocytes prestimulated with angiotensin II. The ratio of heart weight to body weight (mg/g) (4.13 +/- 0.06 in SHRs, 3.77 +/- 0.02 with imperatorin 25 mg kg(-1) d(-1) 16 17 ig, P<0.01) was significantly lower in the imperatorin-treated SHRs. Taken together, our observations show that imperatorin exerts anti-hypertrophic effect both in vitro and in vivo. (C) 2010 Elsevier B.V. All rights reserved.

引用

页码：1188 / 1195

页数：8

共 50 条

[11] Dyxin/Lmcd1 Mediates Cardiac Hypertrophy Both In Vitro And In Vivo
Frank, Derk
Frauen, Robert
Hanselmann, Christiana
Kuhn, Christian
Will, Rainer
Katus, Hugo A.
Frey, Norbert
CIRCULATION, 2008, 118 (18) : S393 - S393
[12] A natural small molecule voacangine inhibits angiogenesis both in vitro and in vivo
Kim, Yonghyo
Jung, Hye Jin
Kwon, Ho Jeong
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2012, 417 (01) : 330 - 334
[13] Ruthenium red potently inhibits immune responses both in vitro and in vivo
Dwyer, DS
Gordon, K
Jones, B
INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY, 1995, 17 (11): : 931 - 940
[14] IL-17 INHIBITS RAT OSTEOGENESIS BOTH IN VITRO AND IN VIVO
Kim, Y. G.
Lee, Y.
OSTEOPOROSIS INTERNATIONAL, 2014, 25 : S177 - S177
[15] Valproic acid inhibits the growth of cervical cancer both in vitro and in vivo
Sami, Siraj
Hoeti, Naseruddin
Xu, Han-Mei
Shen, Zilong
Huang, Xiaofeng
JOURNAL OF BIOCHEMISTRY, 2008, 144 (03): : 357 - 362
[16] Embellistatin, a microtubule polymerization inhibitor, inhibits angiogenesis both in vitro and in vivo
Jung, Hye Jin
Shim, Joong Sup
Lee, Hyang Burm
Kim, Chang-Jin
Kuwano, Takashi
Ono, Mayumi
Kwon, Ho Jeong
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 353 (02) : 376 - 380
[17] Esculetin Inhibits VEGF-Induced Angiogenesis Both In Vitro and In Vivo
Park, Sung Lyea
Won, Se Yeon
Song, Jun-Hui
Lee, Sook-Young
Kim, Wun-Jae
Moon, Sung-Kwon
AMERICAN JOURNAL OF CHINESE MEDICINE, 2016, 44 (01): : 61 - 76
[18] Dyxin/Lmcd1: A Novel Regulator of Cardiomyocyte Hypertrophy Both in Vitro and in Vivo
Frank, Derk
Frauen, Robert
Hanselmann, Christiane
Kuhn, Christian
Will, Rainer
Gantenberg, Johanne
Katus, Hugo A.
Frey, Norbert
CIRCULATION RESEARCH, 2009, 105 (07) : E32 - E32
[19] Carvacrol Ameliorates Pathological Cardiac Hypertrophy in Both In-vivo and In-vitro Models
Jamhiri, Mohabbat
Dahaj, Farzan Safi
Astani, Akram
Hejazian, Seyed Hasan
Haflzibarjin, Zeynab
Ghobadi, Mojtaba
Moradi, Ali
Khoradmehr, Arezu
Safari, Fatemeh
IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (03): : 1380 - 1394
[20] Fucoidan from Fucus vesiculosus Inhibits Inflammatory Response, Both In Vitro and In Vivo
Wang, Lingzhi
Oliveira, Catarina
Li, Qiu
Ferreira, Andreia S.
Nunes, Claudia
Coimbra, Manuel A.
Reis, Rui L.
Martins, Albino
Wang, Chunming
Silva, Tiago H.
Feng, Yanxian
MARINE DRUGS, 2023, 21 (05)

← 1 2 3 4 5 →